Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Beta Drugs Ltd.

May 18, 12:40 NSE 1190.10( -2.20 -0.18%)

Volume1800

Prev. Close
1192.30

Open Price
1205.00

Today's Low / High

1189.00 1230.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

660.00 1595.00

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	227.11	183.84	116.12	90.81	65.93
Total Operating Revenues	227.11	183.84	116.12	90.81	65.93

Other Income	0.75	0.76	0.50	0.41	0.37
Total Revenue	227.87	184.59	116.62	91.22	66.30

EXPENSES
Cost Of Materials Consumed	110.40	96.21	60.55	45.21	37.10
Operating And Direct Expenses	24.29	17.78	13.40	10.33	7.95
Changes In Inventories Of FG,WIP And Stock-In Trade	-4.71	-1.75	-1.77	-0.85	-3.67
Employee Benefit Expenses	22.70	15.91	10.88	9.46	5.27
Finance Costs	2.41	1.90	2.42	2.59	1.43
Depreciation And Amortisation Expenses	10.41	7.25	6.87	3.76	2.84
Other Expenses	21.31	12.99	8.31	8.75	7.48
Total Expenses	186.81	150.29	100.67	79.24	58.40

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	41.06	34.30	15.95	11.97	7.91

Profit/Loss Before Tax	41.06	34.30	15.95	11.97	7.91

Tax Expenses-Continued Operations
Current Tax	10.86	9.51	4.71	2.51	1.69
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	1.54
Deferred Tax	-0.52	-0.03	-0.48	0.05	-0.29
Total Tax Expenses	10.34	9.47	4.23	2.56	-0.13
Profit/Loss After Tax And Before ExtraOrdinary Items	30.72	24.83	11.72	9.42	8.04

Profit/Loss From Continuing Operations	30.72	24.83	11.72	9.42	8.04

Profit/Loss For The Period	30.72	24.83	11.72	9.42	8.04
Consolidated Profit/Loss After MI And Associates	30.72	24.83	11.72	9.42	8.04

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	31.95	25.82	12.20	9.93	9.30
Diluted EPS (Rs.)	31.95	25.82	12.20	9.93	9.30

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	227.11
Total Operating Revenues	227.11
Other Income	0.75
Total Revenue	227.87
EXPENSES
Cost Of Materials Consumed	110.40
Operating And Direct Expenses	24.29
Changes In Inventories Of FG,WIP And Stock-In Trade	-4.71
Employee Benefit Expenses	22.70
Finance Costs	2.41
Depreciation And Amortisation Expenses	10.41
Other Expenses	21.31
Total Expenses	186.81
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	41.06
Profit/Loss Before Tax	41.06
Tax Expenses-Continued Operations
Current Tax	10.86
Less: MAT Credit Entitlement	0.00
Deferred Tax	-0.52
Total Tax Expenses	10.34
Profit/Loss After Tax And Before ExtraOrdinary Items	30.72
Profit/Loss From Continuing Operations	30.72
Profit/Loss For The Period	30.72
Consolidated Profit/Loss After MI And Associates	30.72
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	31.95
Diluted EPS (Rs.)	31.95